SEC Subpoenas Elan For Records Of Tysabri Infection Cases
badproducts.com — Irish drug maker Elan Corp. Plc (ELN) said Tuesday it received a subpoena from the U.S. Securities and Exchange Commission seeking information related to disclosures last year about Elan's multiple-sclerosis drug Tysabri and an experimental Alzheimer's disease drug - disclosures that battered Elan shares. (Submitted by clucca) More...
Another Tysabri Patient has PML | stocks
boston.com — Biogen Idec Inc. reported late yesterday that another patient contracted a potentially fatal brain disease after taking the multiple sclerosis drug Tysabri, the third case since the biotechnology giant reintroduced the treatment two years ago. The news sent shares tumbling 12.1 percent in after-hours trading. (Submitted by inactive) More...
Tysabri: Brain Disease Reported in 2 Patients on M.S. Drug
nytimes.com — Shares of Biogen Idec and Elan Corporation plunged in after-hours trading Thursday after the companies reported two cases of a rare brain disease in patients treated with their multiple sclerosis drug Tysabri. (Submitted by SirPopper) More...
How are these search results? Tell us!
